XML 24 R13.htm IDEA: XBRL DOCUMENT v3.21.1
Long-term debt
3 Months Ended
Mar. 31, 2021
Long-term debts  
Long-term debt

6.    Long-term debt

As of March 31, 2021 and December 31, 2020, long-term debt consisted of the following:

Long-term debt

in € THOUS

 

 

 

 

 

 

 

 

March 31, 

    

December 31, 

 

    

2021

    

2020

 

 

 

 

 

Amended 2012 Credit Agreement

 

1,172,472

 

1,162,342

Bonds

 

5,678,157

 

6,408,118

Accounts Receivable Facility

 

12,793

 

 —

Other

 

237,323

 

238,000

Long-term debt

 

7,100,745

 

7,808,460

Less current portion

 

(785,475)

 

(1,008,359)

Long-term debt, less current portion

 

6,315,270

 

6,800,101

 

The bonds issued by Fresenius Medical Care US Finance, Inc. in the amount of $650,000  (€472,889 as of the date of issuance on February 3, 2011) were redeemed at maturity on February 15, 2021. Additionally, the bonds issued by Fresenius Medical Care Finance VII S.A. on February 3, 2011 in the amount of €300,000 were redeemed at maturity on February 15, 2021.

Amended 2012 Credit Agreement

The following table shows the available and outstanding amounts under the Amended 2012 Credit Agreement at March 31, 2021 and December 31, 2020:

Amended 2012 Credit Agreement - Maximum amount available and balance outstanding

in THOUS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Maximum amount available

 

Balance outstanding

 

 

March 31, 2021

 

March 31, 2021 (1)

 

    

 

 

    

 

 

    

 

 

    

 

 

Revolving credit USD 2017 / 2022

 

$

900,000

 

767,590

 

$

 —

 

 —

Revolving credit EUR 2017 / 2022

 

600,000

 

600,000

 

 —

 

 —

USD term loan 2017 / 2022

 

$

1,080,000

 

921,109

 

$

1,080,000

 

921,109

EUR term loan 2017 / 2022

 

252,000

 

252,000

 

252,000

 

252,000

 

 

 

 

 

2,540,699

 

 

 

 

1,173,109

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Maximum amount available

 

Balance outstanding

 

    

December 31, 2020

    

December 31, 2020 (1)

 

 

 

 

    

 

 

 

 

 

    

 

 

Revolving credit USD 2017 / 2022

 

$

900,000

 

733,436

 

$

 —

 

 —

Revolving credit EUR 2017 / 2022

 

600,000

 

600,000

 

 —

 

 —

USD term loan 2017 / 2022

 

$

1,110,000

 

904,572

 

$

1,110,000

 

904,572

EUR term loan 2017 / 2022

 

259,000

 

259,000

 

259,000

 

259,000

 

 

 

 

 

2,497,008

 

 

 

 

1,163,572


(1)

Amounts shown are excluding debt issuance costs.

Accounts Receivable Facility

The following table shows the available and outstanding amounts under the Accounts Receivable Facility at March 31, 2021 and December 31, 2020:

Accounts Receivable Facility - Maximum amount available and balance outstanding

in THOUS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Maximum amount available

 

Balance outstanding

 

    

March 31, 2021 (1)

    

March 31, 2021 (2)(3)

 

 

 

 

 

 

 

 

 

 

    

 

 

Accounts Receivable Facility

 

$

900,000

 

767,591

 

$

15,000

 

12,793

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Maximum amount available

 

Balance outstanding

 

    

December 31, 2020 (1)

    

December 31, 2020 (2)

 

 

 

 

 

 

 

 

 

 

    

 

 

Accounts Receivable Facility

 

$

900,000

 

733,437

 

$

 —

 

 —


(1)

Subject to availability of sufficient accounts receivable meeting funding criteria.

(2)

Amounts shown are excluding debt issuance costs.

(3)

Included in "Current portion of long-term debt" in the consolidated balance sheet as of March 31, 2021.

The Company also had letters of credit outstanding under the Accounts Receivable Facility in the amount of $12,522 and $12,522  (€10,680 and €10,205) at March 31, 2021 and December 31, 2020, respectively. These letters of credit are not included above as part of the balance outstanding at March 31, 2021 and December 31, 2020; however, they reduce available borrowings under the Accounts Receivable Facility.